HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could two HPV shots be enough for older women? new study aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether two doses of the HPV vaccine work as well as three doses for women aged 27 to 45. About 618 women will be randomly assigned to receive either two or three shots, and their immune response will be checked over 12 months. If two doses prove effective, it co…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 12, 2026 12:08 UTC
-
Could a new HPV test make screening easier for everyone?
Diagnosis Recruiting nowThis study is testing a new, easy-to-use HPV test that could be done at a doctor's office without special lab equipment. Researchers want to see if this new test works as well as the standard HPV test. About 600 people with a cervix, aged 21 or older, will take part. If successfu…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 15, 2026 18:55 UTC
-
Scientists hunt for genetic clues to severe HPV infections
Knowledge-focused Recruiting nowThis study is for people aged 3 and older who have severe, recurring HPV-related warts or lesions that don't respond to standard treatments. Researchers want to learn why some people get sicker from HPV than others by studying their genes and immune systems. Participants will pro…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC